Powles T, Park SH, Caserta C, Valderrama BP, et al. Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Results From the JAVELIN Bladder 100 Trial After >/=2 Years of Follow-Up. J Clin Oncol 2023;41:3486-3492.
PMID: 37071838